101 results
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:22am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:21am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:19am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:18am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
Date (as applicable, a “CVR Payment Date”), pay the aggregate CVR Payment Amount for any non-Employee CVR Holders through the Rights Agent … (for the account of the non-Employee CVR Holders), by wire transfer of immediately available funds to such account as may be designated by the Rights Agent
8-K
EX-3.2
p5s4sdscr
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
8-K
22xfkgwjxru hribem
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
SC 14D9
b5euenls3mj73w 92nh
5 May 23
Tender offer solicitation
8:17am
10-K/A
6kymquaheh
28 Apr 23
Annual report (amended)
4:08pm
8-K
EX-2.2
zhox2hi8enn3uqo8bca4
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
1zny7
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-10.1
c0kluc 6pz7
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-1.1
jl6jtmdkd3fph4k437nc
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
1xzow y1k
3 Nov 22
Prospectus supplement for primary offering
4:42pm